Thursday, May 9, 2019

ALTERED BIOMARKERS OF CARDIOVASCULAR DISEASES IN PEOPLE WITH HIV: THE ASSOCIATION WITH ART DRUGS


PhD Proposal by Robert Rutayisire
W80/53711/2018
University of Nairobi

 

ABSTRACT

Background: In sub-Saharan Africa, a home of more than 70% of people with HIV globally, the emerging NCDs related to lifestyle risk factors raises major concerns to developing countries that requisite to find the right balance in resource distribution to healthcare agendas. In developed countries, the prevention of cardiovascular diseases (CVDs) as a common NCDs in people with HIV, to proper screen for, timely diagnose and treat and more essentially well control its risk factors (such as insulin resistance and hyperlipidemia) have turned out to be the  priorities for clinical care of HIV. This study will determine the impact of ART and HIV-infection on biomarkers of  CVDs among adult people with HIV.
Problem statement: In sub-Saharan Africa, the association of ART and HIV-infection with CVDs has been confounded by the increased prevalence and incidence of NCDs due to changes in lifestyle. Additionally, in Rwanda, only liver and kidney function biological assessments are routinely done during follow-up excluding any assessments for CVD risk factors. Besides there is no clear evidence about the effect of HIV-infection and ART on cardiovascular biomarkers. This study will provide informed evidence about the combined effects of ART and HIV-infection with biomarkers of CVD as risk factors to guide policies for further interventions for prevention and treatment of CVDs among adult people with HIV.
Aim: To determine whether ART and HIV-infection are associated with altered biomarkers of cardiovascular diseases in adult people with HIV living in Rwanda.
Methods: A cohort study will be conducted in people with HIV, attending the Kigali University teaching Hospital (KUTH/CHUK) HIV Clinic and Health Centers in this catchment area for treatment and follow-up health care. Participants will be randomly sampled. Repeated measures design will be used; baseline and 6 months’ follow-up assessments, including an individual interview, completion of a comprehensive health questionnaire, anthropometric measures, biomarkers of cardiovascular diseases including lipid profile, glycated hemoglobin, and insulin, vascular and endothelial function tests, inflammatory and coagulation markers, where blood collection will be performed for CVD related biomarkers assessments.Multivariate analysis of variance (MANOVA) will allow us to test the hypothesis regarding the effect of ART and HIV-infection on CVD related biomarkers.
Expected results: This study will provide longitudinal data about the association of ART and HIV-infection with biomarkers of cardiovascular diseases.
Keywords: HIV-infection, cardiovascular diseases, cardiovascular disease risk factors, highly active antiretroviral therapy, Rwanda.

No comments:

Post a Comment